← Back to Search

Treatment for Primary Sclerosing Cholangitis (WIND-PSC Trial)

N/A
Recruiting
Led By Lisa Henn
Research Sponsored by Arbor Research Collaborative for Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up quarterly for five years from enrollment
Awards & highlights

Summary

Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.

Eligible Conditions
  • Primary Sclerosing Cholangitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~quarterly for five years from enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and quarterly for five years from enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Develop interventional clinical trial external control using clinical and biomarker data.
Secondary outcome measures
Changes in patient reported outcomes over time as assessed by Patient Reported Outcomes surveys.
Identify alternative endpoints to predict clinical benefit using large clinical and biomarker data.

Find a Location

Who is running the clinical trial?

Arbor Research Collaborative for HealthLead Sponsor
20 Previous Clinical Trials
33,467 Total Patients Enrolled
Lisa HennPrincipal InvestigatorArbor Research Collaborative for Health
~1333 spots leftby Jan 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top